How big is the burden of visual loss caused by age related macular degeneration in the United Kingdom?

British Journal of Ophthalmology

Volumn 87, Issue 3, 2003, Pages 312-317

  Owen, Christopher G ^a   Fletcher, A E ^b   Donoghue, M ^b   Rudnicka, A R ^c  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGING; ARTICLE; BINOCULAR VISION; BLINDNESS; FEMALE; HUMAN; MALE; PREVALENCE; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; UNITED KINGDOM; VISUAL ACUITY; VISUAL IMPAIRMENT;

AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; BLINDNESS; FEMALE; GREAT BRITAIN; HEALTH PLANNING; HUMANS; MACULAR DEGENERATION; MALE; PREVALENCE; VISION DISORDERS; VISUAL ACUITY;

EID: 0037340036     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.87.3.312     Document Type: Article

References (53)

1. Leibawitz HM, Krueger DE, Maunder LR, et al. The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol 1980;24:335-610.
2. Rosenberg T, Klie F. The incidence of registered blindness caused by age-related macular degeneration. Acta Ophthalmol Scand 1996;74:399-402.
3. Evans J. Causes of blindness and partial sight in England and Wales 1990-1991: studies on medical and population subjects. No 57. London: HMSO, 1995.
4. Bolatsoukas DD, Siouljs C, Parisi A, et al. Visual handicap in south-east Scotland. J R Coll Surg Edinb 1995;40:49-51.
5. Williams RA, Brady BL, Thomas RG, et al. The psychosocial impact of macular degeneration. Arch Ophthalmol 1998;116:514-20.
6. Arnold JJ, Sarks SH. Age related macular degeneration. BMJ 2000;321:741-4.
7. Ciulla TA, Danis RP, Harris A. Age-related macular degeneration: a review of experimental treatments. Surv Ophthalmol 1998;43:134-46.
8. Ryan B, Culham L. Fragmented vision; survey of low vision services in the UK. London: Royal National Institute for the Blind, 1999.
9. Evans J, Wormald R. Is the incidence of registrable age-related macular degeneration increasing? Br J Ophthalmol 1996;80:9-14.
10. Royal National Institute for the Blind. Office of National Statistics mid-1996 population estimates, estimates for 1996 of visually impaired people (ie, registerable) and the number of people registered blind and partially sighted as at 31st March 1997 in the UK. Available from http://www.rnib.org.uk/wesupply/fctsheet/authuk.html [Accessed March 2000)
11. Bruce IW, McKennell AC, Walker EC. Blind and partially sighted adults in Britain: the RNIB survey. Volume 1. London: HMSO, 1991.
12. Wormald RP, Wright LA, Courtney P, et al. Visual problems in the elderly populations and implications for services. BMJ 1992;304:1226-9.
13. Dickinson AJ, Sparrow JM, Duke AM, et al. Prevalence of age-related maculopathy at two points in time in an elderly Bitish population. Eye 1997;11:301-14.
14. Reidy A, Minassian DC, Vafidis G, et al. Prevalence of serious eye disease and visual impairment in a north London population: population based, crass sectional study. BMJ 1998;316:1643-6.
15. World Health Organization. International statistical classification of diseases and related health problems. 10th revision. Geneva: WHO, 1992.
16. Bird AC, Bressler NM, Bressler SB, et al. An international classification and grading system for age-related maculopathy and age-related macular degeneration. The International ARM Epidemiological Study Group. Surv Ophthalmol 1995;39:367-74.
17. Delcourt C, Diaz JL, Ponton-Sanchez A, et al. Smoking and age-related macular degeneration - the POLA study. Arch Ophthalmol 1998;116:1031-5.
18. Bressler NM, Munoz B, Maguire MG, et al. Five-year incidence and disappearance of drusen and retinal pigment epithelial abnormalities. Waterman study. Arch Ophthalmol 1995;113:301-8
19. Cho EY, Hankinson SE, Willett WC, et al. Prospective study of alcohol consumption and the risk of age- related macular degeneration. Arch Ophthalmol 2000;118:681-8.
20. Christen WG, Glynn RJ, Manson JE, et al. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. JAMA 1996;276:1147-51.
21. Seddon JM, Willett WC, Speizer FE, et al. A prospective study of cigarette smoking and age-related macular degeneration in women. JAMA 1996;276:1141-6.
22. VanNewkirk MR, Nanjan MB, Wang JJ, et al. The prevalence of age-related maculopathy: the visual impairment project. Ophthalmology 2000;107:1593-600.
23. Whitehead A, Whitehead J. A general parametric approach to the meta-analysis of randomized clinical trials. Stat Med 1991;10:1665-77.
24. Thompson SG. Why sources of heterogeneity in meta-analysis should be investigated. BMJ 1994;309:1351-5.
25. Government Actuary's Department (UK). Projected populations at mid-years by age last birthday in five-year age groups. Available from http://www.gad.gov.uk/population/1998/pop5year98-08.html [Accessed April 2001]
26. Gibson JM, Rosenthal AR, Lavery J. A study of the prevalence of eye disease in the elderly in an English community. Trans Ophthalmol Soc UK 1985;104:196-203.
27. Office for National Statistics. Population trends, '96. Summer 99'. London: Stationery Office, 1999.
28. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy. The Beaver Dam Eye Study. Ophthalmology 1992;99:933-43.
29. Vinding T. Visual impairment of age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol (Copenh) 1990;68:162-7.
30. Vinding T. Age-related macular degeneration. An epidemiological study of 1000 elderly individuals. With reference to prevalence funduscopic findings, visual impairment and risk factors. Acta Ophthalmol Scand Suppl 1995:1-32.
31. Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology 1995;102:205-10.
32. Mitchell P, Smith W, Attebo K, et al. Prevalence of age-related maculopothy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995;102:1450-60.
33. VonNewkirk MR, Weih L, McCarty CA, et al. Cause-specific prevalence of bilateral visual impairment in Victoria, Australia: the Visual Impairment Project. Ophthalmology 2001;108:960-7.
34. Weih LM, VanNewkirk MR, McCarty CA, et al. Age-specific causes of bilateral visual impairment. Arch Ophthalmol 2000;118:264-9.
35. Yates JR, Moore AT. Genetic susceptibility to age related macular degeneration. J Med Genet 2000;37:83-7.
36. Cruickshanks KJ, Klein R, Klein BE. Sunlight and age-related macular degeneration. The Beaver Dam Eye Study. Arch Ophthalmol 1993;111:514-18.
37. Smith W, Assink J, Klein R, et al. Risk factors for age-related macular degeneration: pooled findings from three continents. Ophthalmology 2001;108:697-704.
38. Vingerling JR, Klaver CC, Hofman A, et al. Epidemiology of age-related maculopathy. Epidemiol Rev 1995;17:347-60.
39. Munoz B, West SK, Rubin GS, et al. Causes of blindness and visual impairment in a population of older Americans - The Salisbury Eye Evaluation Study. Arch Ophthalmol 2000;118:819-25.
40. Jonasson F, Thardarson K. Prevalence of ocular disease and blindness in a rural area in the eastern region of Iceland during 1980 through 1984. Acta Ophthalmol Suppl 1987;182:40-3.
41. Vinding T. Age-related macular degeneration. Macular changes prevalence and sex ratio. An epidemiological study of 1000 aged individuals. Acta Ophthalmol (Copenh) 1989;67:609-16.
42. Bunce C, Evans J, Fraser S, et al. BDB certification of visually impaired people. Br J Ophthalmol 1998;82:72-6.
43. Robinson R, Deutsch J, Janes HS, et al. Unrecognised and unregistered visual impairment. Br J Ophthalmol 1994;78:736-40.
44. Vinding T. Visual impairment of age-related macular degeneration. An epidemiological study of 1000 aged individuals. Acta Ophthalmol (Copenh) 1990;68:162-7.
45. Rovner BW, Zisselman PM, Shmuely-Dulitzki Y. Depression and disability in older people with impaired vision: a follow-up study. J Am Geriatr Soc 1996;44:181-4.
46. Stuck AE, Walthert JM, Nikolaus T, et al. Risk factors for functional status decline in community-living elderly people: a systematic literature review. Soc Sci Med 1999;48:445-69.
47. Grisso JA, Kelsey JL, Strom BL, et al. Risk factors for falls as a cause of hip fracture in women. The Northeast Hip Fracture Study Group. N Engl J Med 1991;324:1326-31.
48. Harries U, Landes R, Papay J. Visual disability among older people: a case study in assessing needs and examining services. J Public Health Med 1994;16:211-18.
49. Margrain TH. Helping blind and partially sighted people to read: the effectiveness of low vision aids. Br J Ophthalmol 2000;84:919-21.
50. Shuttleworth GN, Dunlop A, Collins JK, et al. How effective is an integrated approach to low vision rehabilitation? Two year follow up results from south Devon. Br J Ophthalmol 1995;79:719-23.
51. Department of Health. The NHS plan: a plan for investment, a plan for reform. London: Stationery Office, 2000.
52. Department of Health. Modernising social services: promoting independence, improving protection, raising standards. London: Stationery Office, 1998.
53. Low Vision Consensus Group. Low vision services: recommendations for future service delivery in the UK. London: The Royal National Institute for the Blind, 1999.